Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Dudareva

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Epidemiology and Infection|September 26, 2025
Evidence of very low hepatitis B virus prevalence in children and adolescents in Germany: National cross-sectional study, 2014-2017Sofie Gillesberg Lassen, Christina Poethko-Müller, Martin Schlaud, et al.
Frontiers in Public Health|April 1, 2022
Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019Anna Maisa, Christian Kollan, Matthias An der Heiden, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 8, 2024
Self-reported hepatitis A and B vaccination coverage among men who have sex with men (MSM), associated factors and vaccination recommendations in 43 countries of the WHO European Region: results from the European MSM Internet Survey, EMIS-2017Michael Brandl, Axel J Schmidt, Ulrich Marcus, et al.
BMC Public Health|June 3, 2024
Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general populationAlyona Mazhnaya, Brogan Geurts, Krestina Brigida, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|February 1, 2020
Dieter Glebe, Florian van Bömmel, Sandra Dudareva, et al.
Frontiers in Public Health|October 5, 2020
Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping ReviewIda Sperle, Gyde Steffen, Siv Aina Leendertz, et al.
JMIR Research Protocols|May 28, 2025
Barriers and Facilitators to HIV and Viral Hepatitis Testing in Primary Health Care Settings in the Kyrgyz Republic (BarTest): Protocol for a Mixed Methods StudyIda Sperle, Nikolay Lunchenkov, Zuridin S Nurmatov, et al.
IJID Regions|February 22, 2024
Evaluating the hepatitis B vaccination impact in the Republic of Moldova: A nationwide representative serosurvey of children born in 2013Michael Brandl, Alexei Ceban, Octavian Sajin, et al.
BMC Infectious Diseases|January 23, 2025
Nationwide representative serosurvey of third-grade school children to evaluate the hepatitis B vaccination impact in Kyrgyzstan, 2022Michael Brandl, Gulnara Zhumagulova, Gulbara Ishenapysova, et al.
The Lancet Regional Health. Europe|April 13, 2026
Liver cirrhosis and hepatocellular carcinoma attributable to hepatitis B and C in Kyrgyzstan, 2019-2024: a prospective and retrospective studyMichael Brandl, Zuridin Nurmatov, Gulsunai Sattarova, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Epidemiology and Infection|September 26, 2025
Evidence of very low hepatitis B virus prevalence in children and adolescents in Germany: National cross-sectional study, 2014-2017Sofie Gillesberg Lassen, Christina Poethko-Müller, Martin Schlaud, et al.
Frontiers in Public Health|April 1, 2022
Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019Anna Maisa, Christian Kollan, Matthias An der Heiden, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 8, 2024
Self-reported hepatitis A and B vaccination coverage among men who have sex with men (MSM), associated factors and vaccination recommendations in 43 countries of the WHO European Region: results from the European MSM Internet Survey, EMIS-2017Michael Brandl, Axel J Schmidt, Ulrich Marcus, et al.
BMC Public Health|June 3, 2024
Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general populationAlyona Mazhnaya, Brogan Geurts, Krestina Brigida, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|February 1, 2020
Dieter Glebe, Florian van Bömmel, Sandra Dudareva, et al.
Frontiers in Public Health|October 5, 2020
Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping ReviewIda Sperle, Gyde Steffen, Siv Aina Leendertz, et al.
JMIR Research Protocols|May 28, 2025
Barriers and Facilitators to HIV and Viral Hepatitis Testing in Primary Health Care Settings in the Kyrgyz Republic (BarTest): Protocol for a Mixed Methods StudyIda Sperle, Nikolay Lunchenkov, Zuridin S Nurmatov, et al.
IJID Regions|February 22, 2024
Evaluating the hepatitis B vaccination impact in the Republic of Moldova: A nationwide representative serosurvey of children born in 2013Michael Brandl, Alexei Ceban, Octavian Sajin, et al.
BMC Infectious Diseases|January 23, 2025
Nationwide representative serosurvey of third-grade school children to evaluate the hepatitis B vaccination impact in Kyrgyzstan, 2022Michael Brandl, Gulnara Zhumagulova, Gulbara Ishenapysova, et al.
The Lancet Regional Health. Europe|April 13, 2026
Liver cirrhosis and hepatocellular carcinoma attributable to hepatitis B and C in Kyrgyzstan, 2019-2024: a prospective and retrospective studyMichael Brandl, Zuridin Nurmatov, Gulsunai Sattarova, et al.
Pageof 5